Extracorporeal Membrane Oxygenation Machine Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

ECMO is a life support system that is to treat severe cardiac disorders such as cardiac shock or arrest, and they act as a heart and lungs outside the body. In ECMO a machine purifies the blood and makes a pathway for the blood circulation outside the body. It sends oxygen-filled blood into the human body and takeout the carbon dioxide-filled blood outside the body and the whole process is done in this ECMO therapy. Thus, due to the increase in the prevalence of CVD coupled with growing awareness of the benefits of ECMO such as maintaining the supply of oxygen to the body while resting the lungs, the market is projected to witness considerable CAGR during the forecast period.

In U.S., about 18 million adults aged 20 and older have coronary artery disease (CAD). Furthermore, according to American Heart Association (AHA), coronary heart diseases cause 1 in every 7 deaths in the U.S., resulting in about 366,800 deaths each year. In addition, in 2020, there were 2.2 million new cases of lung cancer reported.  

According to UnivDatos Market Insights (UMI)’ research report “ECMO machines Market”, the market is expected to witness a CAGR growth of around 5% during the forecast period 2021-2027F. The extracorporeal membrane oxygenation machine market is projected to grow at a CAGR of 5% from 2019 to 2027 to reach USD XX billion by 2027.

Request to Download Sample of this Strategic Report – https://univdatos.com/get-a-free-sample-form-php/?product_id=20196  

Based on modality, the market is segmented into veno-arterial, veno-venous, and arterial-venous. Among these segments, arterial-venous (VA-ECMO) is projected to attain the largest market share in 2021 and is expected to increase with a healthy CAGR in the forecast period. The prevalence of Arterial-venous (VA-ECMO) promotes gas exchange, especially the removal of carbon dioxide, by pumping blood into the circulatory system using the patient's arterial pressure. 

Based on application, the market is bifurcated into cardiac, respiratory, and extracorporeal cardiopulmonary resuscitation (ECPR). Among these three, Respiratory accounted for the largest market share in 2021. The growth of the segment owes to the increase in the prevalence of chronic diseases entwined with the rising aged population in developing countries, which, in turn, fuels the need for Cardiac surgeries.

Request to Download Sample of this Strategic Report – https://univdatos.com/get-a-free-sample-form-php/?product_id=20196

North America Dominates the ECMO machines Market

For a better understanding of the market, the report is analyzed based on different regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain Rest of Europe); Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific); and Rest of World. North America accounts for the largest share of the market. Furthermore, the U.S. acquired the largest share in the North American market owing to the increasing prevalence of unhealthy lifestyles in youth coupled with the rising geriatric population in the country. According to the US Census Bureau analysis, the elderly population is expected to nearly double in the next 25 years. Furthermore, the increment in the global prevalence of multiple cardiovascular diseases like coronary artery diseases (CAD), and respiratory diseases are the major factors for the growth of this market. In 2020, according to the World Health Organization, there are 227,875 new lung cancer cases diagnosed. According to World Population Ageing, in 2019, the elderly population of North America was 59.9 million which is expected to reach 96.2 million by 2050. 

According to UnivDatos Market Insights (UMI)’, Some of the major players operating in the market Fresenius Medical Care AG & Co. KGaA, Getinge Group, Medtronic plc, Terumo Cardiovascular Systems Corporation, Nipro Corporation, Xenios AG, Alung Technologies, Inc., Livanova plc, Eurosets S.R.L., Abiomed.

For more informative information, please visit us – https://univdatos.com/report/extracorporeal-membrane-oxygenation-machine-market/

“ECMO machines Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.      

Market Segmentation:

1.     By Modality (Veno-arterial, Veno-Venous, Arterial-venous)

2.     By Component (Pumps, Oxygenators, Controllers, Cannula, Accessories)

3.     By Application (Cardiac, Respiratory, Extracorporeal cardiopulmonary resuscitation (ECPR))

4.     By End-User (Hospitals & Clinics, Ambulatory Surgery centers, and others)

5.     By Region (North America, Europe, Asia-Pacific, Rest of World)

6.     By Company (Fresenius Medical Care AG & Co. KGaA, Getinge Group, Medtronic plc, Terumo Cardiovascular Systems Corporation, Nipro Corporation, Xenios AG, Alung Technologies, Inc., Livanova plc, Eurosets S.R.L., Abiomed.)

Key questions answered in the study:

1.     What are the current and future trends of the ECMO machines industry?

2.     How the industry has been evolving in terms of the component, modality, application, and end-user?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the ECMO machines industry?

5.     What is the customer orientation, purchase behavior, and expectations from the ECMO machines product suppliers across various countries?  

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET COVID-19 IMPACT

6 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY MODALITY

8 MARKET INSIGHTS BY APPLICATION

9 MARKET INSIGHTS BY COMPONENT

10 MARKET INSIGHTS BY END-USER

11 MARKET INSIGHTS BY REGION

12 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE SOFTWAREMARKET DYNAMICS

13 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET OPPORTUNITIES

14 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

19 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       Hand Sanitizer Market Size Worth US$ 15.3 Billion by 2026 |CAGR: 9.15%|

·       Healthcare Cybersecurity Market to Reach US$ 41.8 Mn Billion by 2027 Globally |CAGR: 19.8%| 

·       Aesthetic Medicine Market to exceed US$ 19 Billion by 2027 Globally |CAGR: 10.5%|

·       Venous Stents Market to exceed US$ 2 Billion by 2027 Globally |CAGR: 9%|